Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-p2v8j Total loading time: 0 Render date: 2024-05-12T11:04:28.024Z Has data issue: false hasContentIssue false

Chapter 5 - Dementias

from Section 2 - Mental disorders

Published online by Cambridge University Press:  05 March 2016

By
Jennifer Torr
Edited by
Colin Hemmings  and
Nick Bouras
Colin Hemmings
Affiliation:
Albion Place Medical Centre
Nick Bouras
Affiliation:
Institute of Psychiatry, London
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Psychiatric and Behavioral Disorders in Intellectual and Developmental Disabilities , pp. 55 - 64
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders – Text Revision, Fourth Edition. Washington, DC: American Psychiatric Association.Google Scholar
American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington, DC: American Psychiatric Association.Google Scholar
Ball, S.L., Holland, A.J., Hon, J., et al. (2006). Personality and behaviour changes mark the early stages of Alzheimer’s disease in adults with Down’s syndrome: findings from a prospective population-based study. International Journal of Geriatric Psychiatry, 21(7), 661–673.CrossRefGoogle ScholarPubMed
Ball, S.L., Holland, A.J., Treppner, P., Watson, P.C., Huppert, F.A. (2008). Executive dysfunction and its association with personality and behaviour changes in the development of Alzheimer’s disease in adults with Down syndrome and mild to moderate learning disabilities. British Journal of Clinical Psychology, 47(1), 1–29.CrossRefGoogle ScholarPubMed
Boada-Rovira, M., Hernandez-Ruiz, I., Badenas-Homiar, S., Buendia-Torras, M., Tarraga-Mestre, L. (2005). Clinical-therapeutic study of dementia in people with Down syndrome and the effectiveness of donepezil in this population. Revista de Neurologia, 41(3), 129–136.Google ScholarPubMed
Carlock, K.S., Williams, J.P., Graves, G.C. (1997). MRI findings in headbangers. Clinical Imaging, 21(6), 411–413.CrossRefGoogle ScholarPubMed
Chace, C., Pang, D., Weng, C., et al. (2012). Variants in CYP17 and CYP19 cytochrome P450 genes are associated with onset of Alzheimer’s disease in women with Down syndrome. Journal of Alzheimer’s Disease, 28(3), 601–612.CrossRefGoogle ScholarPubMed
Cooper, S.A. (1997). High prevalence of dementia among people with learning disabilities not attributable to Down’s syndrome. Psychological Medicine, 27(3), 609–616.CrossRefGoogle Scholar
Coppus, A., Evenhuis, H., Verberne, G.-J., et al. (2006). Dementia and mortality in persons with Down’s syndrome. Journal of Intellectual Disability Research, 50(10), 768–777.CrossRefGoogle ScholarPubMed
Coppus, A., Evenhuis, H., Verberne, G.-J., et al. (2008). Survival in elderly persons with Down syndrome. Journal of the American Geriatrics Society, 56(12), 2311–2316.CrossRefGoogle ScholarPubMed
Courtenay, K., Jokinen, N.S., Strydom, A. (2010). Caregiving and adults with intellectual disabilities affected by dementia. Journal of Policy and Practice in Intellectual Disabilities, 7(1), 26–33.CrossRefGoogle Scholar
Frighi, V., Morovat, A., Stephenson, M.T., et al. (2014). Vitamin D deficiency in patients with intellectual disabilities: prevalence, risk factors and management strategies. British Journal of Psychiatry, 205(6), 458–464.CrossRefGoogle ScholarPubMed
Gedye, A. (1998). Neuroleptic-induced dementia documented in four adults with mental retardation. Mental Retardation, 36(3), 182–186.2.0.CO;2>CrossRefGoogle ScholarPubMed
Hanney, M., Prasher, V., Williams, N., et al. (2012). Memantine for dementia in adults older than 40 years with Down’s syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial. Lancet, 379(9815), 528–536.CrossRefGoogle Scholar
Hartley, S.L., Handen, B.L., Devenny, D.A., et al. (2014). Cognitive functioning in relation to brain amyloid-β in healthy adults with Down syndrome. Brain, 137(9), 2556–2563.CrossRefGoogle ScholarPubMed
Haveman, M.J., Heller, T., Lee, L.A., et al. (2009). Report on the State of Science on Health Risks and Ageing in People with Intellectual Disabilities. Dortmund, Germany: IASSID Special Interest Research Group on Ageing and Intellectual Disabilities/Faculty Rehabilitation Sciences, University of Dortmund.Google Scholar
Jamieson-Craig, R., Scior, K., Chan, T., Fenton, C., Strydom, A. (2010). Reliance on carer reports of early symptoms of dementia among adults with intellectual disabilities. Journal of Policy and Practice in Intellectual Disabilities, 7(1), 34–41.CrossRefGoogle Scholar
Jones, E.L., Margallo-Lana, M., Prasher, V.P., Ballard, C.G. (2008). The extended tau haplotype and the age of onset of dementia in Down syndrome. Dementia and Geriatric Cognitive Disorders, 26(3), 199–202.CrossRefGoogle ScholarPubMed
Jones, E.L., Hanney, M., Francis, P.T., Ballard, C.G. (2009). Amyloid β concentrations in older people with Down syndrome and dementia. Neuroscience Letters, 451(2), 162–164.CrossRefGoogle ScholarPubMed
Kondoh, T., Amamoto, N., Doi, T., et al. (2005a). Dramatic improvement in Down syndrome-associated cognitive impairment with donepezil. Annals of Pharmacotherapy, 39(3), 563–566.CrossRefGoogle ScholarPubMed
Kondoh, T., Nakashima, M., Sasaki, H., Moriuchi, H. (2005b). Pharmacokinetics of donepezil in Down syndrome. Annals of Pharmacotherapy, 39(3), 572–573.CrossRefGoogle ScholarPubMed
Koran, M.E., Hohman, T., Edwards, C., et al. (2014). Differences in age-related effects on brain volume in Down syndrome as compared to Williams syndrome and typical development. Journal of Neurodevelopmental Disorders, 6(1), 8.CrossRefGoogle ScholarPubMed
Littlejohns, T.J., Henley, W.E., Lang, I.A., et al. (2014). Vitamin D and the risk of dementia and Alzheimer disease. Neurology, 83(10), 920–928.CrossRefGoogle ScholarPubMed
Lott, I.T., Osann, K., Doran, E., Nelson, L. (2002). Down syndrome and Alzheimer disease: response to donepezil. Archives of Neurology, 59(7), 1133–1136.CrossRefGoogle ScholarPubMed
Mantry, D., Cooper, S.A., Smiley, E., et al. (2008). The prevalence and incidence of mental ill-health in adults with Down syndrome. Journal of Intellectual Disability Research, 52(2), 141–155.CrossRefGoogle ScholarPubMed
McCarron, M., Gill, M., McCallion, P., Begley, C. (2005). Health co-morbidities in ageing persons with Down syndrome and Alzheimer’s dementia. Journal of Intellectual Disability Research, 49(7), 560–566.CrossRefGoogle ScholarPubMed
McShane, R., Areosa, S.A., Minakaran, N. (2006). Memantine for dementia (review). Cochrane Database of Systemic Review, 2, CD003154.Google Scholar
Mohan, M., Bennett, C., Carpenter, P.K. (2009a). Galantamine for dementia in people with Down syndrome. Cochrane Database of Systematic Reviews, 1, CD007657.Google Scholar
Mohan, M., Bennett, C., Carpenter, P.K. (2009b). Memantine for dementia in people with Down syndrome. Cochrane Database of Systematic Reviews, 1, CD007657.Google Scholar
Mohan, M., Bennett, C., Carpenter, P.K. (2009c). Rivastigmine for dementia in people with Down syndrome. Cochrane Database of Systematic Reviews, 1, CD007658.Google Scholar
Mohan, M., Carpenter, P.K., Bennett, C. (2009d). Donepezil for dementia in people with Down syndrome. Cochrane Database of Systematic Reviews, 1, CD007178.Google Scholar
Mulcahy, M.T. (1979). Down’s syndrome in Western Australia: cytogenetics and incidence. Human Genetics, 48(1), 67–72.CrossRefGoogle ScholarPubMed
Nelson, L.D., Siddarth, P., Kepe, V., et al. (2011). Positron emission tomography of brain β-amyloid and tau levels in adults with Down syndrome. Archives of Neurology 68, 768–774.CrossRefGoogle ScholarPubMed
Prasher, V. (2004). Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer’s disease in adults with Down syndrome: implications for the intellectual disability population. International Journal of Geriatric Psychiatry, 19(6), 505–515.CrossRefGoogle ScholarPubMed
Prasher, V. (ed.) (2009). Neuropsychological Assessments of Dementia in Down Syndrome and Intellectual Disabilities. London: Springer-Verlag.CrossRefGoogle Scholar
Prasher, V.P., Barber, P.C., West, R., Glenholmes, P. (1996). The role of magnetic resonance imaging in the diagnosis of Alzheimer disease in adults with Down syndrome. Archives of Neurology, 53(12), 1310–1313.CrossRefGoogle ScholarPubMed
Prasher, V.P., Farrer, M.J., Kessling, A.M., et al. (1998). Molecular mapping of Alzheimer-type dementia in Down’s syndrome. Annals of Neurology, 43(3), 380–383.CrossRefGoogle ScholarPubMed
Prasher, V.P., Huxley, A., Haque, M.S., Down Syndrome Ageing Study Group (2002). A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer’s disease – pilot study. International Journal of Geriatric Psychiatry, 17(3), 270–278.CrossRefGoogle ScholarPubMed
Prasher, V.P., Adams, C., Holder, R. (2003). Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer’s disease in adults with Down syndrome: open label study. International Journal of Geriatric Psychiatry, 18(6), 549–551.CrossRefGoogle ScholarPubMed
Prasher, V.P., Fung, N., Adams, C. (2005). Rivastigmine in the treatment of dementia in Alzheimer’s disease in adults with Down syndrome. International Journal of Geriatric Psychiatry, 20(5), 496–497.CrossRefGoogle ScholarPubMed
Royal College of Psychiatrists (2001). Diagnostic Criteria for Psychiatric Disorders for Use with Adults with Learning Disabilities/Mental Retardation (DC-LD). London: Royal College of Psychiatrists.Google Scholar
Saxton, J., McGonigle, K.L., Swihart, A.A., Boller, F. (1993). The Severe Impairment Battery. Bury St. Edmunds, Norfolk, UK: Thames Valley Test Company.Google Scholar
Schupf, N. and Sergievsky, G.H. (2002). Genetic and host factors for dementia in Down’s syndrome. British Journal of Psychiatry, 180, 405–410.CrossRefGoogle ScholarPubMed
Schupf, N., Patel, B., Silverman, W., et al. (2001). Elevated plasma amyloid beta-peptide 1–42 and onset of dementia in adults with Down syndrome. Neuroscience Letters, 301(3), 199–203.CrossRefGoogle ScholarPubMed
Stoll, C., Alembik, Y., Dott, B., Roth, M.P. (1998). Study of Down syndrome in 238,942 consecutive births. Annales de Genetique, 41(1), 44–51.Google Scholar
Strydom, A., Hassiosis, A., Walker, Z. (2002). Clinical use of structural magnetic resonance imaging in the diagnosis of dementia in adults with Down’s syndrome. Irish Journal of Psychological Medicine, 19(2), 60–63.CrossRefGoogle Scholar
Strydom, A., Livingston, G., King, M., Hassiotis, A. (2007). Prevalence of dementia in intellectual disability using different diagnostic criteria. British Journal of Psychiatry, 191, 150–157.CrossRefGoogle ScholarPubMed
Strydom, A., Hassiotis, A., King, M., Livingston, G. (2009). The relationship of dementia prevalence in older adults with intellectual disability (ID) to age and severity of ID. Psychological Medicine, 39(1), 13–21.CrossRefGoogle ScholarPubMed
Strydom, A., Romeo, R., Perez-Achiaga, N., et al. (2010a). Service use and cost of mental disorder in older adults with intellectual disability. British Journal of Psychiatry, 196(2), 133–138.CrossRefGoogle ScholarPubMed
Strydom, A., Shooshtari, S., Lee, L.A., et al. (2010b). Dementia in older adults with intellectual disabilities – epidemiology, presentation and diagnosis. Journal of Policy and Practice in Intellectual Disabilities, 7(2), 96–110.CrossRefGoogle Scholar
Strydom, A., Chan, T., Fenton, C., et al. (2013a). Validity of criteria for dementia in older people with intellectual disability. American Journal of Geriatric Psychiatry, 21(3), 279–288.CrossRefGoogle ScholarPubMed
Strydom, A., Chan, T., King, M., et al. (2013b). Incidence of dementia in older adults with intellectual disabilities. Research in Developmental Disabilities, 34(6), 1881–1885.CrossRefGoogle ScholarPubMed
Torr, J. (2009). Assessment of dementia in people with learning disabilities. Advances in Mental Health and Learning Disabilities, 3(3), 3–9.CrossRefGoogle Scholar
Torr, J., Carling-Jenkins, R., Iacono, T., Bigby, C. (2010a). Pathways to assessment and diagnosis of dementia in adults with Down syndrome. Journal of Applied Research in Intellectual Disabilities, 23(5), 408–418.Google Scholar
Torr, J., Strydom, A., Patti, P., Jokinen, N. (2010b). Ageing in Down syndrome: morbidity and mortality. Journal of Policy and Practice in Intellectual Disabilities, 7(1), 70–81.CrossRefGoogle Scholar
Tyrrell, J., Cosgrave, M., McCarron, M., et al. (2001). Dementia in people with Down’s syndrome. International Journal of Geriatric Psychiatry, 16(12), 1168–1174.CrossRefGoogle ScholarPubMed
Urv, T., Zigman, W.B., Silverman, W. (2010). Psychiatric symptoms in adults with Down syndrome and Alzheimer’s disease. American Journal on Intellectual and Developmental Disabilities, 115(4), 265–276.CrossRefGoogle ScholarPubMed
Wegiel, J., Dowjat, K., Kaczmarski, W., et al. (2008). The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome. Acta Neuropathologica, 116(4), 391–407.CrossRefGoogle ScholarPubMed
Wisniewski, K.E., Wisniewski, H.M., Wen, G.Y. (1985). Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome. Annals of Neurology, 17(3), 278–282.CrossRefGoogle ScholarPubMed
Witts, P. and Elders, S. (1998). The “Severe Impairment Battery”: assessing cognitive ability in adults with Down syndrome. British Journal of Clinical Psychology, 37(2), 213–216.CrossRefGoogle ScholarPubMed
Wolvetang, E.W., Bradfield, O.M., Tymms, M., et al. (2003). The chromosome 21 transcription factor ETS2 transactivates the beta-APP promoter: implications for Down syndrome. Biochimica et Biophysica Acta, 1628(2), 105–10.Google ScholarPubMed
World Health Organization (1993) ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: World Health Organization.Google Scholar
Zeilinger, E.L., Stiehl, K.A.M., Weber, G. (2013). A systematic review on assessment instruments for dementia in persons with intellectual disabilities. Research in Developmental Disabilities, 34(11), 3962–3977.CrossRefGoogle ScholarPubMed
Zigman, W.B., Schupf, N., Jenkins, E.C., et al. (2007). Cholesterol level, statin use and Alzheimer’s disease in adults with Down syndrome. Neuroscience Letters, 416(3), 279–284.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Dementias
  • Edited by Colin Hemmings, Nick Bouras, Institute of Psychiatry, London
  • Book: Psychiatric and Behavioral Disorders in Intellectual and Developmental Disabilities
  • Online publication: 05 March 2016
  • Chapter DOI: https://doi.org/10.1017/CBO9781107588714.006
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Dementias
  • Edited by Colin Hemmings, Nick Bouras, Institute of Psychiatry, London
  • Book: Psychiatric and Behavioral Disorders in Intellectual and Developmental Disabilities
  • Online publication: 05 March 2016
  • Chapter DOI: https://doi.org/10.1017/CBO9781107588714.006
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Dementias
  • Edited by Colin Hemmings, Nick Bouras, Institute of Psychiatry, London
  • Book: Psychiatric and Behavioral Disorders in Intellectual and Developmental Disabilities
  • Online publication: 05 March 2016
  • Chapter DOI: https://doi.org/10.1017/CBO9781107588714.006
Available formats
×